BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/24/2020 11:59:07 AM | Browse: 682 | Download: 923
 |
Received |
|
2020-01-19 18:48 |
|
Peer-Review Started |
|
2020-01-19 18:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-12 23:02 |
|
Revised |
|
2020-05-05 04:19 |
|
Second Decision |
|
2020-05-12 08:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-05-13 06:37 |
|
Articles in Press |
|
2020-05-13 06:37 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-05-18 10:19 |
|
Publish the Manuscript Online |
|
2020-05-24 11:59 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Minireviews |
| Article Title |
Formulation strategies in immunotherapeutic pharmaceutical products
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yajie Zhang, Robert O Williams III and Haley Oana Tucker |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Haley Oana Tucker, PhD, Professor, Departments of Bioengineering and Molecular Biosciences, The University of Texas at Austin, 1 University Station A5000, Austin, TX 78712, United States. haleytucker@austin.utexas.edu |
| Key Words |
Immunotherapeutic; Pharmaceutical products; Formulation; Excipients; Cell therapy; Antibody |
| Core Tip |
In this review, we have focused on the formulation strategies and excipients that have been used in commercialized antibody products as well as the formulation concerns for immuno-cell therapy. Development of immunologic-based biopharmaceutical products have strikingly increased in recent years and have made evident contributions to human health. Antibodies are the leading entity in immunotherapy, while chimeric antigen receptor T cells therapies are the advent of a novel strategy in this area. |
| Publish Date |
2020-05-24 11:59 |
| Citation |
Zhang Y, Williams RO III, Tucker HO. Formulation strategies in immunotherapeutic pharmaceutical products. World J Clin Oncol 2020; 11(5): 275-282 |
| URL |
https://www.wjgnet.com/2218-4333/full/v11/i5/275.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v11.i5.275 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
